These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35333703)

  • 41. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.
    Claus R; Lucas DM; Stilgenbauer S; Ruppert AS; Yu L; Zucknick M; Mertens D; Bühler A; Oakes CC; Larson RA; Kay NE; Jelinek DF; Kipps TJ; Rassenti LZ; Gribben JG; Döhner H; Heerema NA; Marcucci G; Plass C; Byrd JC
    J Clin Oncol; 2012 Jul; 30(20):2483-91. PubMed ID: 22564988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones.
    Osman A; Gocke CD; Gladstone DE
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):97-99. PubMed ID: 28041846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.
    Huang YJ; Kuo MC; Chang H; Wang PN; Wu JH; Huang YM; Ma MC; Tang TC; Kuo CY; Shih LY
    Br J Haematol; 2019 Oct; 187(1):82-92. PubMed ID: 31230372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.
    Queirós AC; Villamor N; Clot G; Martinez-Trillos A; Kulis M; Navarro A; Penas EM; Jayne S; Majid A; Richter J; Bergmann AK; Kolarova J; Royo C; Russiñol N; Castellano G; Pinyol M; Bea S; Salaverria I; López-Guerra M; Colomer D; Aymerich M; Rozman M; Delgado J; Giné E; González-Díaz M; Puente XS; Siebert R; Dyer MJ; López-Otín C; Rozman C; Campo E; López-Guillermo A; Martín-Subero JI
    Leukemia; 2015 Mar; 29(3):598-605. PubMed ID: 25151957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
    Mansouri L; Thorvaldsdottir B; Sutton LA; Karakatsoulis G; Meggendorfer M; Parker H; Nadeu F; Brieghel C; Laidou S; Moia R; Rossi D; Catherwood M; Kotaskova J; Delgado J; Rodríguez-Vicente AE; Benito R; Rigolin GM; Bonfiglio S; Scarfo L; Mattsson M; Davis Z; Gogia A; Rani L; Baliakas P; Foroughi-Asl H; Jylhä C; Skaftason A; Rapado I; Miras F; Martinez-Lopez J; de la Serna J; Rivas JMH; Thornton P; Larráyoz MJ; Calasanz MJ; Fésüs V; Mátrai Z; Bödör C; Smedby KE; Espinet B; Puiggros A; Gupta R; Bullinger L; Bosch F; Tazón-Vega B; Baran-Marszak F; Oscier D; Nguyen-Khac F; Zenz T; Terol MJ; Cuneo A; Hernández-Sánchez M; Pospisilova S; Mills K; Gaidano G; Niemann CU; Campo E; Strefford JC; Ghia P; Stamatopoulos K; Rosenquist R
    Leukemia; 2023 Feb; 37(2):339-347. PubMed ID: 36566271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mutational features of immunoglobulin heavy chain variable region gene in patients with chronic lymphocytic leukemia].
    Li YH; Huang XQ; Lin YN; Chen XJ; Chen L; Liu EB; Mi YC; Ru K
    Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1135-1140. PubMed ID: 36323543
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV.
    Poppova L; Janovska P; Plevova K; Radova L; Plesingerova H; Borsky M; Kotaskova J; Kantorova B; Hlozkova M; Figulova J; Brychtova Y; Machalova M; Urik M; Doubek M; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Br J Haematol; 2016 Dec; 175(5):851-859. PubMed ID: 27651098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
    Mitsui T; Koiso H; Nakahashi H; Saitoh A; Shimizu H; Ishizaki T; Ogawa Y; Takizawa M; Yokohama A; Saitoh T; Jinbo T; Ogura H; Handa H; Sawamura M; Sakura T; Karasawa M; Murakami H; Nojima Y; Tsukamoto N
    Int J Hematol; 2016 Feb; 103(2):219-26. PubMed ID: 26588928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.
    Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I
    Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
    Galligan L; Catherwood MA; Matthews C; Morris TC; Alexander HD
    Leuk Lymphoma; 2008 Apr; 49(4):763-8. PubMed ID: 18398745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
    Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia.
    Abreu C; Moreno P; Palacios F; Borge M; Morande P; Landoni AI; Gabus R; Dighiero G; Giordano M; Gamberale R; Oppezzo P
    Leuk Lymphoma; 2013 Aug; 54(8):1844-8. PubMed ID: 23614796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
    Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.